Cerebrospinal Fluid Management - Medical Devices Pipeline Assessment, 2017

2017-09-01
Price :
Published : Sep-2017
No. of Pages : 94
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 7
2 Introduction 8
2.1 Cerebrospinal Fluid Management Overview 8
3 Products under Development 9
3.1 Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
3.2 Cerebrospinal Fluid Management - Pipeline Products by Segment 10
3.3 Cerebrospinal Fluid Management - Pipeline Products by Territory 11
3.4 Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
3.5 Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
3.6 Cerebrospinal Fluid Management - Ongoing Clinical Trials 14
4 Cerebrospinal Fluid Management - Pipeline Products under Development by Companies 15
4.1 Cerebrospinal Fluid Management Companies - Pipeline Products by Stage of Development 15
4.2 Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 17
5 Cerebrospinal Fluid Management Companies and Product Overview 18
5.1 Alcyone Lifesciences Inc Company Overview 18
5.1.1 Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
5.2 Aqueduct Neurosciences Company Overview 21
5.2.1 Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 21
5.3 Arkis BioSciences Company Overview 22
5.3.1 Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 22
5.4 Beckersmith Medical, Inc. Company Overview 23
5.4.1 Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
5.5 Biosan Medical Ltd. Company Overview 24
5.5.1 Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
5.6 CereVasc LLC Company Overview 25
5.6.1 CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 25
5.7 Georgia Institute of Technology Company Overview 26
5.7.1 Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26
5.8 H-Cubed Inc. Company Overview 27
5.8.1 H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
5.9 Integra LifeSciences Holdings Corp Company Overview 28
5.9.1 Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28
5.10 InVivo Therapeutics Corp Company Overview 30
5.10.1 InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 30
5.11 Kerecis ehf Company Overview 33
5.11.1 Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
5.12 Kuros Biosciences AG Company Overview 34
5.12.1 Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
5.13 Microbot Medical Ltd Company Overview 35
5.13.1 Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
5.14 Monitor Med Solutions Company Overview 38
5.14.1 Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 38
5.15 Nanonerve Inc. Company Overview 39
5.15.1 Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
5.16 NeuraMedica, LLC Company Overview 40
5.16.1 NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 40
5.17 NexGen Medical Systems Inc Company Overview 41
5.17.1 NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 41
5.18 Nurami Medical Ltd Company Overview 42
5.18.1 Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
5.19 Sree Chitra Tirunal Institute for Medical Sciences & Technology Company Overview 43
5.19.1 Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 43
5.20 System Science Inc. Company Overview 45
5.20.1 System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
5.21 University Hospital Zurich Company Overview 47
5.21.1 University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 47
5.22 University of Rochester Company Overview 48
5.22.1 University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
5.23 University of South Florida Company Overview 49
5.23.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 49
5.24 University of Wisconsin Madison Company Overview 51
5.24.1 University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 51
5.25 Vivonics, Inc. Company Overview 53
5.25.1 Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
5.26 Wayne State University Company Overview 54
5.26.1 Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 54
6 Cerebrospinal Fluid Management Management- Recent Developments 55
6.1 Aug 22, 2017: Medtronic Reports First Quarter Financial Results 55
6.2 Jul 31, 2017: Dr. Joachim Schulz joins the Management Board of B. Braun Melsungen 57
6.3 Jul 27, 2017: LeMaitre Q2 2017 Record Sales $25.8 mm (+15%), Record EPS $0.23 (+69%) 57
6.4 Jul 26, 2017: Integra LifeSciences Reports Second Quarter 2017 Financial Results 58
6.5 Jul 10, 2017: InVivo Therapeutics Appoints Richard Toselli, M.D. as Chief Medical Officer 59
6.6 Jun 21, 2017: Kuros receives CE certification for Neuroseal, a novel dural sealant 60
6.7 Jun 14, 2017: Microbot Medical Continues to Solidify IP Portfolio with US Patent for Previously Disclosed Device for Preventing Shunt Stenosis 61
6.8 Jun 08, 2017: B. Braun is participating in the third edition of the High-Tech Founders Fund 61
6.9 May 31, 2017: Microbot Medical Announces Issuance Of A Canadian Patent Covering A Self-Cleaning Shunt 62
6.10 May 31, 2017: Depuy Synthes and Ethicon to Showcase Intra Operative Solutions Aiming to Mitigate Surgical Site Infection During Efort Congress 62
6.11 May 25, 2017: Medtronic Reports Fourth Quarter and Fiscal Year 2017 Financial Results 64
6.12 Apr 26, 2017: LeMaitre Q1 2017 Record Sales $24.1 mm (+19%), Net Income $3.2 mm (+49%) 67
6.13 Apr 26, 2017: Integra LifeSciences Reports First Quarter 2017 Financial Results 67
6.14 Apr 12, 2017: Change in the B. Braun Management Board and the Aesculap Management Board 68
6.15 Apr 06, 2017: Medtronic Announces Voluntary Worldwide Recall Of Its StrataMR Adjustable Valves And Shunts 69
6.16 Mar 31, 2017: B. Braun continues its sales and earnings growth 69
6.17 Mar 13, 2017: Cook Medical Announces Umesh Patel as President of Cook Biotech 71
6.18 Mar 07, 2017: TGA Announces Hazard Alert for Medtronic StrataMR Adjustable Valves and Shunts 72
6.19 Mar 07, 2017: Anteo Technologies Announces Verification Study With Cook Medical Australia 72
6.20 Feb 23, 2017: Integra LifeSciences Reports Fourth Quarter and Full-Year 2016 Financial Results and Updates 2017 Full-Year Guidance 73
6.21 Feb 22, 2017: Microbot Medical Inc. Announces Significant Technology Patent Allowance in the U.S. 75
6.22 Feb 22, 2017: Change in the B. Braun Management Board 75
6.23 Feb 21, 2017: Medtronic Reports Third Quarter Financial Results 75
6.24 Feb 21, 2017: LeMaitre Q4 2016 Record Sales $23.3 mm (+14%), Op. Income $3.9 mm (+27%) 78
6.25 Feb 06, 2017: Medtronic Awarded U.S. Department of Veterans Affairs National Contracts for Home Telehealth Technologies, with Three Other Vendors 79
6.26 Dec 21, 2016: Kuros submits regulatory filing seeking CE certification for Neuroseal, a novel dural sealant 79
6.27 Dec 05, 2016: Integra LifeSciences announces management changes 80
6.28 Dec 05, 2016: Integra LifeSciences Announces Key Executive Appointments 80
6.29 Nov 22, 2016: Medtronic Reports Second Quarter Financial Results 81
6.30 Nov 16, 2016: Medtronic Releases FY16 Integrated Performance Report 84
6.31 Nov 15, 2016: CEVA to work with Medtronic for distribution facility construction 84
6.32 Nov 14, 2016: HyperBranch Medical Technology Launches Innovative Adherus AutoSpray Extended Tip (ET) Dural Sealant for Cranial Neurosurgery 85
6.33 Nov 04, 2016: InVivo Therapeutics Reports 2016 Third Quarter Financial Results and Business Update 86
6.34 Oct 27, 2016: Integra LifeSciences Reports Third Quarter 2016 Financial Results 87
6.35 Oct 26, 2016: LeMaitre Q3 2016 Record Sales $23.2 mm (+22%), Record Op. Income $5.3 mm (+61%) 88
6.36 Oct 12, 2016: HyperBranch Medical Wins Decision Against Integra Lifesciences 88
6.37 Sep 15, 2016: Medtronic Names Mark Ploof Senior Vice President of Global Operations and Business Services 89
7 Appendix 91
7.1 Methodology 91
7.2 About GlobalData 94
7.3 Contact Us 94
7.4 Disclaimer 94

1.1 List of Tables
Table 1: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
Table 2: Cerebrospinal Fluid Management - Pipeline Products by Segment 10
Table 3: Cerebrospinal Fluid Management - Pipeline Products by Territory 11
Table 4: Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
Table 5: Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
Table 6: Cerebrospinal Fluid Management - Ongoing Clinical Trials 14
Table 7: CSF Management Companies - Pipeline Products by Stage of Development 15
Table 8: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 17
Table 9: Alcyone Lifesciences Inc Pipeline Products & Ongoing Clinical Trials Overview 18
Table 10: ReFlow Ventricular System - Product Status 18
Table 11: ReFlow Ventricular System - Product Description 18
Table 12: Alcyone Lifesciences Inc - Ongoing Clinical Trials Overview 19
Table 13: ReFlow Ventricular System - Quantitative Characterization of Safe Irrigation for Ventricular Shunt Catheters 20
Table 14: Aqueduct Neurosciences Pipeline Products & Ongoing Clinical Trials Overview 21
Table 15: Smart Shunt - Product Status 21
Table 16: Smart Shunt - Product Description 21
Table 17: Arkis BioSciences Pipeline Products & Ongoing Clinical Trials Overview 22
Table 18: Arkis AutoShunt - Product Status 22
Table 19: Arkis AutoShunt - Product Description 22
Table 20: Beckersmith Medical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 23
Table 21: FlowSafe - Product Status 23
Table 22: FlowSafe - Product Description 23
Table 23: Biosan Medical Ltd. Pipeline Products & Ongoing Clinical Trials Overview 24
Table 24: Ventritek105 - Product Status 24
Table 25: Ventritek105 - Product Description 24
Table 26: CereVasc LLC Pipeline Products & Ongoing Clinical Trials Overview 25
Table 27: eShunt - Product Status 25
Table 28: eShunt - Product Description 25
Table 29: Georgia Institute of Technology Pipeline Products & Ongoing Clinical Trials Overview 26
Table 30: Hydrocephalus Shunt - Product Status 26
Table 31: Hydrocephalus Shunt - Product Description 26
Table 32: H-Cubed Inc. Pipeline Products & Ongoing Clinical Trials Overview 27
Table 33: Ambulatory System For Hydrocephalus Shunt - Product Status 27
Table 34: Ambulatory System For Hydrocephalus Shunt - Product Description 27
Table 35: Integra LifeSciences Holdings Corp Pipeline Products & Ongoing Clinical Trials Overview 28
Table 36: Hydrocephalic Shunt - Product Status 28
Table 37: Hydrocephalic Shunt - Product Description 28
Table 38: Next Generation DuraSeal - Product Status 29
Table 39: Next Generation DuraSeal - Product Description 29
Table 40: Ventricular Drainage Device - Product Status 29
Table 41: Ventricular Drainage Device - Product Description 29
Table 42: InVivo Therapeutics Corp Pipeline Products & Ongoing Clinical Trials Overview 30
Table 43: Dural Graft - Product Status 30
Table 44: Dural Graft - Product Description 30
Table 45: InVivo Therapeutics Corp - Ongoing Clinical Trials Overview 31
Table 46: Dural Graft - A Study to Evaluate the Use of SOMVC001 (GALA) Vascular Conduit Preservation Solution in Patients Undergoing Coronary Artery Bypass Grafting (CABG) 32
Table 47: Kerecis ehf Pipeline Products & Ongoing Clinical Trials Overview 33
Table 48: Kerecis Omega3 Dura - Product Status 33
Table 49: Kerecis Omega3 Dura - Product Description 33
Table 50: Kuros Biosciences AG Pipeline Products & Ongoing Clinical Trials Overview 34
Table 51: Neuroseal - Cranial - Product Status 34
Table 52: Neuroseal - Cranial - Product Description 34
Table 53: Microbot Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 35
Table 54: Self-Cleaning Shunt (SCS) Device - Product Status 35
Table 55: Self-Cleaning Shunt (SCS) Device - Product Description 35
Table 56: Microbot Medical Ltd - Ongoing Clinical Trials Overview 36
Table 57: Self-Cleaning Shunt (SCS) Device - Clinical Investigation of Self-Cleaning Shunt (SCS) Device 37
Table 58: Monitor Med Solutions Pipeline Products & Ongoing Clinical Trials Overview 38
Table 59: Hydrocephalus Shunt System - Product Status 38
Table 60: Hydrocephalus Shunt System - Product Description 38
Table 61: Nanonerve Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 62: Nanofibrous Dural Substitute - Product Status 39
Table 63: Nanofibrous Dural Substitute - Product Description 39
Table 64: NeuraMedica, LLC Pipeline Products & Ongoing Clinical Trials Overview 40
Table 65: Dural Clip - Product Status 40
Table 66: Dural Clip - Product Description 40
Table 67: NexGen Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 41
Table 68: EViTAR FLOWMETER - Product Status 41
Table 69: EViTAR FLOWMETER - Product Description 41
Table 70: Nurami Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 42
Table 71: Dural Substitute Patch - Product Status 42
Table 72: Dural Substitute Patch - Product Description 42
Table 73: Sree Chitra Tirunal Institute for Medical Sciences & Technology Pipeline Products & Ongoing Clinical Trials Overview 43
Table 74: Bovine Pericardium - Dura Substitute - Product Status 43
Table 75: Bovine Pericardium - Dura Substitute - Product Description 43
Table 76: Programmable Hydrocephalus Stent - Product Status 44
Table 77: Programmable Hydrocephalus Stent - Product Description 44
Table 78: System Science Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 79: Acute Cerebrospinal Fluid Monitor And Control System - Product Status 45
Table 80: Acute Cerebrospinal Fluid Monitor And Control System - Product Description 45
Table 81: Implantable Cerebrospinal Fluid Monitor And Control System - Product Status 46
Table 82: Implantable Cerebrospinal Fluid Monitor And Control System - Product Description 46
Table 83: University Hospital Zurich Pipeline Products & Ongoing Clinical Trials Overview 47
Table 84: SmartShunt - Product Status 47
Table 85: SmartShunt - Product Description 47
Table 86: University of Rochester Pipeline Products & Ongoing Clinical Trials Overview 48
Table 87: Catheterless Shunt System - Product Status 48
Table 88: Catheterless Shunt System - Product Description 48
Table 89: University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 49
Table 90: Shunt Catheter System With Inline Filter - Product Status 49
Table 91: Shunt Catheter System With Inline Filter - Product Description 49
Table 92: Sonic Window Cranioplasty Implant - Product Status 50
Table 93: Sonic Window Cranioplasty Implant - Product Description 50
Table 94: University of Wisconsin Madison Pipeline Products & Ongoing Clinical Trials Overview 51
Table 95: Gravity And Pressure Controlled Valve System - Product Status 51
Table 96: Gravity And Pressure Controlled Valve System - Product Description 51
Table 97: Hydrocephalus Stent - Product Status 52
Table 98: Hydrocephalus Stent - Product Description 52
Table 99: Vivonics, Inc. Pipeline Products & Ongoing Clinical Trials Overview 53
Table 100: Shunt Flowmeter - Product Status 53
Table 101: Shunt Flowmeter - Product Description 53
Table 102: Wayne State University Pipeline Products & Ongoing Clinical Trials Overview 54
Table 103: Programmable Antisiphon Shunt System - Product Status 54
Table 104: Programmable Antisiphon Shunt System - Product Description 54
Table 105: Glossary 93

1.2 List of Figures
Figure 1: Cerebrospinal Fluid Management - Pipeline Products by Stage of Development 9
Figure 2: Cerebrospinal Fluid Management - Pipeline Products by Segment 10
Figure 3: Cerebrospinal Fluid Management - Pipeline Products by Territory 11
Figure 4: Cerebrospinal Fluid Management - Pipeline Products by Regulatory Path 12
Figure 5: Cerebrospinal Fluid Management - Pipeline Products by Estimated Approval Date 13
Figure 6: Cerebrospinal Fluid Management - Ongoing Clinical Trials 14
Filed in: Medical Device
Publisher : GlobalData